Tapewire

NYSE · USD

VNRX

VOLITIONRX LTD

Export transactions ↓
Tapewire entity
8241
SEC CIK
0000093314
Parsed reports
530

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2024 Filed Dec 3, 2024 21:01 UTC GrantCommon Stock 17,296 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007808 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,321

F1 · shares: On December 1, 2024, the reporting person was awarded 17,296 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,766 units, 5,765 units, and 5,765 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Forterre GaelChief Commercial Officer
GrantCommon Stock 4,828 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007807 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,181

F1 · shares: On December 1, 2024, the reporting person was awarded 4,828 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 1,610 units, 1,609 units, and 1,609 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Rubin EthelDirector
GrantCommon Stock 8,648 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007806 · form4.xml · nonDerivative · entry 1

Rubin Ethel · CIK 0002038290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,648

F1 · shares: On December 1, 2024, the reporting person was awarded 8,648 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,883 units, 2,883 units, and 2,882 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Kway JasmineCEO, Singapore Volition
GrantCommon Stock 15,169 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007805 · form4.xml · nonDerivative · entry 1

Kway Jasmine · CIK 0001808135 · CEO, Singapore Volition

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,072

F1 · shares: On December 1, 2024, the reporting person was awarded 15,169 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,057 units, 5,056 units, and 5,056 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Colman AlanDirector
GrantCommon Stock 12,972 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007804 · form4.xml · nonDerivative · entry 1

Colman Alan · CIK 0001577873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,524

F1 · shares: On December 1, 2024, the reporting person was awarded 12,972 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 4,324 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
GrantCommon Stock 13,143 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007803 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,709

F1 · shares: On December 1, 2024, the reporting person was awarded 13,143 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 4,381 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Nguyen KimDirector
GrantCommon Stock 8,648 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007802 · form4.xml · nonDerivative · entry 1

Nguyen Kim · CIK 0001852492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,516

F1 · shares: On December 1, 2024, the reporting person was awarded 8,648 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,883 units, 2,883 units, and 2,882 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Hughes TerigChief Financial Officer
GrantCommon Stock 12,683 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007801 · form4.xml · nonDerivative · entry 1

Hughes Terig · CIK 0001841309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,252

F1 · shares: On December 1, 2024, the reporting person was awarded 12,683 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,228 units, 4,228 units, and 4,227 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Retter AndrewChief Medical Officer
GrantCommon Stock 9,365 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007800 · form4.xml · nonDerivative · entry 1

Retter Andrew · CIK 0002015252 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,475

F1 · shares: On December 1, 2024, the reporting person was awarded 9,365 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,122 units, 3,122 units, and 3,121 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:01 UTC
Butera Salvatore ThomasCEO, Volition Veterinary
GrantCommon Stock 16,871 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-007799 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO, Volition Veterinary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,590

F1 · shares: On December 1, 2024, the reporting person was awarded 16,871 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,624 units, 5,624 units, and 5,623 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 21:34 UTC GrantCommon Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-006919 · form4.xml · nonDerivative · entry 2

STILL TIMOTHY I · CIK 0001200616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,400,000

F2 · shares: The reporting person received 1,000,000 RSUs under the Issuer's 2024 Stock Incentive Plan, subject to vesting in two equal installments of 500,000 units upon the achievement of a closing stock price target above $2.50 per share and above $5.00 per share, respectively, of the Issuer's common stock for a minimum of thirty consecutive trading days prior to November 6, 2027, which date shall be no earlier than November 6, 2025, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all. Vesting of the RSUs shall be accelerated to fully-vest the rights to these RSUs if the Issuer undergoes a Change of Control (as defined in the Award) at a purchase price per share of the Issuer's common stock in such transaction exceeding $2.50 per share. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 21:34 UTC GrantCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-006919 · form4.xml · nonDerivative · entry 1

STILL TIMOTHY I · CIK 0001200616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

F1 · shares: The reporting person received 400,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, vesting in three installments of 133,334 units, 133,333 units, and 133,333 units on each of November 6, 2025, November 6, 2026 and November 6, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC
Butera Salvatore ThomasCEO, Volition Veterinary
Tax withholdingCommon Stock 5,834 $0.88 $5,151.42
Disclosure

SEC source: 0001477932-24-006286 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO, Volition Veterinary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,719

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
Tax withholdingCommon Stock 6,110 $0.88 $5,395.13
Disclosure

SEC source: 0001477932-24-006285 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,566

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC Tax withholdingCommon Stock 4,620 $0.88 $4,079.46
Disclosure

SEC source: 0001477932-24-006284 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,816

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC
Forterre GaelChief Commercial Officer
Tax withholdingCommon Stock 5,433 $0.88 $4,797.34
Disclosure

SEC source: 0001477932-24-006283 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,353

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC
Plummer NicholasGC, Volition Diagnostics
Tax withholdingCommon Stock 8,146 $0.88 $7,192.92
Disclosure

SEC source: 0001477932-24-006282 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,618

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:01 UTC
Micallef Jacob VincentChief Scientific Officer
Tax withholdingCommon Stock 5,200 $0.88 $4,591.60
Disclosure

SEC source: 0001477932-24-006281 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,661

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 30, 2024 Filed Sep 30, 2024 20:38 UTC
Rubin EthelDirector
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-006042 · form4.xml · nonDerivative · entry 1

Rubin Ethel · CIK 0002038290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: The reporting person received 15,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, vesting in three equal installments of 5,000 units on each of September 30, 2025, September 30, 2026 and September 30, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:06 UTC
Forterre GaelChief Commercial Officer
Tax withholdingCommon Stock 4,824 $0.58 $2,788.27
Disclosure

SEC source: 0001477932-24-006102 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,786

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,725 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:06 UTC
Micallef Jacob VincentChief Scientific Officer
Tax withholdingCommon Stock 4,950 $0.58 $2,861.10
Disclosure

SEC source: 0001477932-24-006101 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 355,861

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,375 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:06 UTC
Plummer NicholasGC Volition Diagnostics
Tax withholdingCommon Stock 1,497 $0.58 $865.27
Disclosure

SEC source: 0001477932-24-006100 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,764

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,525 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:05 UTC Tax withholdingCommon Stock 4,158 $0.58 $2,403.32
Disclosure

SEC source: 0001477932-24-006099 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,436

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:05 UTC
Butera Salvatore ThomasCEO Volition Veterinary
Tax withholdingCommon Stock 5,230 $0.58 $3,022.94
Disclosure

SEC source: 0001477932-24-006098 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO Volition Veterinary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,553

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 19,125 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 28, 2024 Filed Oct 1, 2024 20:05 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
Tax withholdingCommon Stock 5,604 $0.58 $3,239.11
Disclosure

SEC source: 0001477932-24-006097 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,676

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,925 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:06 UTC
Plummer NicholasGC - Volition Diagnostics
GrantCommon Stock 12,043 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005494 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,261

F1 · shares: On September 1, 2024, the reporting person was awarded 12,043 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,015 units, 4,014 units, and 4,014 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:05 UTC
Forterre GaelChief Commercial Officer
GrantCommon Stock 10,240 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005503 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,610

F1 · shares: On September 1, 2024, the reporting person was awarded 10,240 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,414 units, 3,413 units, and 3,413 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:05 UTC
Retter AndrewChief Medical Officer
GrantCommon Stock 9,784 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005501 · form4.xml · nonDerivative · entry 1

Retter Andrew · CIK 0002015252 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,110

F1 · shares: On September 1, 2024, the reporting person was awarded 9,784 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,262 units, 3,261 units, and 3,261 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:04 UTC
Kway JasmineCEO - Singapore Volition
GrantCommon Stock 15,668 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005507 · form4.xml · nonDerivative · entry 1

Kway Jasmine · CIK 0001808135 · CEO - Singapore Volition

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,903

F1 · shares: On September 1,2024, the reporting person was awarded 15,668 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,223 units, 5,223 units, and 5,222 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:04 UTC
Micallef Jacob VincentChief Scientific Officer
GrantCommon Stock 47,837 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005506 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,811

F1 · shares: On September 1, 2024, the reporting person was awarded 47,837 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 15,946 units, 15,946 units, and 15,945 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:04 UTC GrantCommon Stock 18,342 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005505 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,025

F1 · shares: On September 1, 2024, the reporting person was awarded 18,342 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 6,114 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:04 UTC
Michel GaetanChief Operating Officer
GrantCommon Stock 15,671 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005504 · form4.xml · nonDerivative · entry 1

Michel Gaetan · CIK 0001709503 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,120

F1 · shares: On September 1, 2024, the reporting person was awarded 15,671 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,224 units, 5,224 units, and 5,223 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:03 UTC
Reynolds Cameron JohnDirector · President and CEO
GrantCommon Stock 103,243 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005502 · form4.xml · nonDerivative · entry 1

Reynolds Cameron John · CIK 0001340610 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,977,593

F1 · shares: On September 1, 2024, the reporting person was awarded 103,243 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 34,415 units, 34,414 units, and 34,414 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:03 UTC
Colman AlanDirector
GrantCommon Stock 13,757 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005500 · form4.xml · nonDerivative · entry 1

Colman Alan · CIK 0001577873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,552

F1 · shares: On September 1, 2024, the reporting person was awarded 13,757 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,586 units, 4,586 units, and 4,585 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:02 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
GrantCommon Stock 13,731 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005499 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,280

F1 · shares: On September 1, 2024, the reporting person was awarded 13,731 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 4,577 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:02 UTC
Hughes TerigChief Financial Officer
GrantCommon Stock 13,493 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005498 · form4.xml · nonDerivative · entry 1

Hughes Terig · CIK 0001841309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,569

F1 · shares: On September 1, 2024, the reporting person was awarded 13,493 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,498 units, 4,498 units, and 4,497 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:02 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
GrantCommon Stock 35,783 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005497 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,783

F1 · shares: On September 1, 2024, the reporting person was awarded 35,783 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 11,928 units, 11,928 units, and 11,927 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:02 UTC GrantCommon Stock 15,258 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005496 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,594

F1 · shares: On September 1, 2024, the reporting person was awarded 15,258 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 5,086 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:01 UTC GrantCommon Stock 9,171 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005495 · form4.xml · nonDerivative · entry 1

Barnes Phillip · CIK 0001790293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,368

F1 · shares: On September 1, 2024, the reporting person was awarded 9,171 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 3,057 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 20:01 UTC
Nguyen KimDirector
GrantCommon Stock 9,171 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005493 · form4.xml · nonDerivative · entry 1

Nguyen Kim · CIK 0001852492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,868

F1 · shares: On September 1, 2024, the reporting person was awarded 9,171 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 3,057 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Read SEC document
August 20, 2024 Filed Aug 21, 2024 12:26 UTC PurchaseCommon Stock 150,000 $0.67 $100,500.00
Disclosure

SEC source: 0001477932-24-005169 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 406,683

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC
Nguyen KimDirector
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005034 · form4.xml · nonDerivative · entry 1

Nguyen Kim · CIK 0001852492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,697

F1 · shares: On Sept 28, 2023, the reporting person was awarded 20,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 1,666 units, 1,667 units, and 1,667 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 8,500 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 6,500 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC
Plummer NicholasGC, Volition Diagnostics
GrantCommon Stock 17,250 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005033 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,218

F1 · shares: On Sept 28, 2023, the reporting person was awarded 69,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 5,750 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 29,325 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 22,425 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005032 · form4.xml · nonDerivative · entry 1

Barnes Phillip · CIK 0001790293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,197

F1 · shares: On Sept 28, 2023, the reporting person was awarded 20,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 1,666 units, 1,667 units, and 1,667 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 8,500 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 6,500 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
GrantCommon Stock 13,250 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005031 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,549

F1 · shares: On Sept 28, 2023, the reporting person was awarded 53,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 4,416 units, 4,417 units, and 4,417 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 22,525 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 17,225 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005030 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,683

F1 · shares: On Sept 28, 2023, the reporting person was awarded 20,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 1,666 units, 1,667 units, and 1,667 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 8,500 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 6,500 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC
Forterre GaelChief Commercial Officer
GrantCommon Stock 15,250 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005029 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,370

F1 · shares: On Sept 28, 2023, the reporting person was awarded 61,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 15,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 5,083 units, 5,083 units, and 5,084 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 25,925 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 19,825 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:06 UTC
Kway JasmineCEO, Singapore Volition
GrantCommon Stock 16,750 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005028 · form4.xml · nonDerivative · entry 1

Kway Jasmine · CIK 0001808135 · CEO, Singapore Volition

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,235

F1 · shares: On Sept 28, 2023, the reporting person was awarded 67,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 16,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 5,583 units, 5,583 units, and 5,584 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 28,475 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 21,775 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:05 UTC GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005027 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,336

F1 · shares: On Sept 28, 2023, the reporting person was awarded 44,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 11,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,666 units, 3,667 units, and 3,667 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 18,700 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 14,300 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:05 UTC
Butera Salvatore ThomasCEO, Volition Veterinary
GrantCommon Stock 21,250 $0.00 $0.00
Disclosure

SEC source: 0001477932-24-005026 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO, Volition Veterinary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,000

F1 · shares: On Sept 28, 2023, the reporting person was awarded 85,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 21,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 7,083 units, 7,083 units, and 7,084 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 36,125 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 27,625 RSUs did not vest and were cancelled on August 15, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.